Martin P Grobusch
Overview
Explore the profile of Martin P Grobusch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
436
Citations
6785
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong H, Grobusch M
Curr Opin HIV AIDS
. 2025 Mar;
PMID: 40048580
Purpose Of Review: Although cases of Zika virus disease (ZVD) have declined globally since 2017, new outbreaks have been reported, such as in Asia in 2024. As there is no...
2.
Tamarozzi F, Mazzi C, Antinori S, Arsuaga M, Becker S, Bocanegra C, et al.
Travel Med Infect Dis
. 2025 Feb;
64:102822.
PMID: 39983934
Background: The diagnostic and treatment approaches for schistosomiasis in individual patients, outside endemic areas, are not standardised. This study aimed to appraise the reference documents that the experts from the...
3.
Grobusch M, Pellejero-Sagastizabal G, Jokelainen P, Lescure F, Mora-Rillo M, Gupta N
Clin Microbiol Infect
. 2025 Feb;
PMID: 39954953
No abstract available.
4.
De Pijper C, van Thiel P, van de Beek D, Brouwer M, Aronica E, Juffermans N, et al.
Travel Med Infect Dis
. 2025 Feb;
64:102813.
PMID: 39922333
Background: Only few rabies survivors have been described in the medical literature, of whom most suffered severe neurological sequelae. Published treatment protocols have not been applied successfully. Yet, experimental treatments...
5.
Adegbite B, Dreyer V, Agbo J, Mevyann R, Mfoumbi G, Ndanga M, et al.
IJID Reg
. 2025 Jan;
14():100501.
PMID: 39802816
Objectives: This study aimed to investigate genotypic characteristics and drug resistance profiles of complex (Mtbc) strains isolated from patients with suspected tuberculosis (TB) in Gabon. Methods: We performed whole genome...
6.
Vas Nunes J, van Duinen A, Boateng D, Tommy A, Sankoh O, Grobusch M, et al.
Heliyon
. 2025 Jan;
11(1):e38693.
PMID: 39802020
Objectives: This wound section of the PREvalence Study on Surgical COnditions (PRESSCO) determines the incidence and prevalence of wounds and burns in Sierra Leone. It further describes access to wound...
7.
Hedrich N, Bekker-Nielsen Dunbar M, Grobusch M, Schlagenhauf P
Travel Med Infect Dis
. 2025 Jan;
64:102799.
PMID: 39800038
Introduction: Aedes-borne arboviral infections, both imported and autochthonous, are reported in Europe. We evaluated the landscape of these infections in Europe over 23 years and attempted to pre-empt the trajectory...
8.
Pereira S, Grobusch M, Hanscheid T
New Microbes New Infect
. 2025 Jan;
63:101552.
PMID: 39759404
No abstract available.
9.
Kleine L, Kanu E, Grebe T, Sesay D, Loismann H, Sesay M, et al.
Int J Med Microbiol
. 2025 Jan;
318:151643.
PMID: 39756087
Background: Nasopharyngeal colonization with Staphylococcus aureus is a risk factor for subsequent infection. Isolates from colonization can therefore provide important information on virulence factors and antimicrobial resistance when data from...
10.
Hanscheid T, Mahomed S, Rebelo M, Henriques S, Grobusch M
New Microbes New Infect
. 2024 Dec;
62:101544.
PMID: 39719945
Background: Accurate scientific terminology is crucial in health sciences to avoid misinterpretations. The use of 'artemisinin resistance' to describe delayed parasite clearance may be inaccurately equated with full resistance, as...